Login

Healthcare

00:10:00
Jean-Claude Maurel Shares Optimism and Insights on Enhancing SME Financing | Jean-Claude Maurel, CEO, Medesis Pharma SA.
00:10:00
Dr. Bernard Lee on Fibromyalgia: Shedding Light on the Causes of Chronic Pain Disorder | Dr Bernard Lee Mun Kam, CEO, Singapore Paincare Holdings Ltd.
00:10:00
Andreas Gerward Discusses Stayble Therapeutics' Breakthrough Product STA363, Market Scope, and Capital Strategy | Andreas Gerward, CEO, Stayble Therapeutic AB.
00:10:00
Jean-Claude Maurel on Medesis Pharma’s €7M IPO and Future Plans | Jean-Claude Maurel, CEO, Medesis Pharma SA.
00:10:00
Dr. Bernard Lee: Guiding Pain Management at Singapore Pain Care Center, Paragon Medical | Dr Bernard Lee Mun Kam, CEO, Singapore Paincare Holdings Ltd.
00:10:00
Revolutionizing Drug Delivery: Medesis Pharma's Breakthrough with Aonys Technology | Jean-Claude Maurel, CEO, Medesis Pharma SA.
00:10:00
Jean-Claude Maurel of Medesis Pharma on Nanomicelle Technology's Promise in Alzheimer's Treatment | Jean-Claude Maurel, CEO, Medesis Pharma SA.
00:10:00
Stayble Therapeutics' Andreas Gerward on Capital Raise, New Ownership, and Near-Term Milestones | Andreas Gerward, CEO, Stayble Therapeutic AB.
00:10:00
Singapore Paincare Holdings Celebrates SBR National Business Award for DR+ Medical & Paincare | Dr Bernard Lee Mun Kam, CEO, Singapore Paincare Holdings Ltd.
00:10:00
Jean-Claude Maurel on Medesis Pharma’s Strategy for Controlling Inflammatory Cytokine Storms | Jean-Claude Maurel, CEO, Medesis Pharma SA.
00:10:00
A 25-Year Veteran Leading Bausch + Lomb's Next Chapter in Healthcare |Brent Saunders , CEO, Bausch + Lomb Corp.
00:10:00
Andreas Gerward, CEO of Stayble Therapeutics, Shares Expertise on Clinical Trials in Eastern Europe and Industry Challenges | Andreas Gerward, CEO, Stayble Therapeutic AB.
00:10:00
Brent Saunders: The Visionary CEO Behind $300 Billion in Mergers & Acquisitions |Brent Saunders , CEO, Bausch + Lomb Corp.
00:10:00
Andreas Gerward Represents Stayble Therapeutics at NLSDays, Sharing Developments in Life Science | Andreas Gerward, CEO, Stayble Therapeutic AB.
00:10:00
Reimagining the Workplace: Brent Saunders on the Permanent Shift to Remote Work |Brent Saunders , CEO, Bausch + Lomb Corp.
00:10:00
Andreas Gerward of Stayble Therapeutics on Treatment Methods and Anticipated Q4'24 Data | Andreas Gerward, CEO, Stayble Therapeutic AB.

© 2026 Nehu